- Home
- LPA vs ZTEK Comparison
LPA vs ZTEK Comparison
Compare LPA & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LPA | ZTEK |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | | |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.3M | 78.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LPA | ZTEK |
|---|---|---|
| Price | $2.45 | $0.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.6K | ★ 70.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.25 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.04 | $0.60 |
| 52 Week High | $10.03 | $1.84 |
Technical Indicators
Market Signals| Indicator | LPA | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | 34.38 |
| Support Level | $2.33 | $0.62 |
| Resistance Level | $2.67 | $0.69 |
| Average True Range (ATR) | 0.20 | 0.07 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 46.53 | 4.02 |
Price Performance
Historical ComparisonAbout LPA Logistic Properties of the Americas
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.